Ruben Maeso is a Scientist II at Seqirus, where they have been contributing since 2017. They completed a PhD in Science at the University of Basque Country, focusing on the structural and functional study of broadly neutralizing antibodies against HIV-1. Prior to their current role, Ruben worked as a Postdoctoral Research Associate at the Centre for Integrative Biology from 2012 to 2014 and as a PostDoc-Scientist at MedImmune - AstraZeneca from 2014 to 2017, where they investigated factors influencing vaccine stability and viral integration. Ruben holds both a Master's degree in Biomedicine and Molecular Biology and a Bachelor's degree in Biochemistry, both from the University of Basque Country.
This person is not in the org chart
This person is not in any teams
This person is not in any offices